Added to YB: 2025-08-08
Pitch date: 2025-07-09
DHR [neutral]
Danaher Corporation
+12.57%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$162.8B
Pitch Price
$201.05
Price Target
N/A
Dividend
0.56%
EV/EBITDA
22.57
P/E
47.35
EV/Sales
7.39
Sector
Life Sciences Tools and Services
Category
N/A
Pender Strategic Growth and Income Fund Portfolio Holding: Danaher Corporation
DHR (holding update): Leading life sciences/diagnostics platform with 80% recurring revenue from consumables/service contracts. Danaher Business System drives operational improvement and disciplined M&A. COVID-related sales decline and inventory destocking creating temporary headwinds, not altering long-term thesis.
Read full article (1 min)